• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经蝶窦垂体瘤切除术术中磁共振成像的应用:趋势和医疗保健利用。

Intraoperative MRI use in transsphenoidal surgery for pituitary tumors: Trends and healthcare utilization.

机构信息

Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, United States; Department of Neurosurgery, University of Minnesota, MMC 96, 420 Delaware St. SE, Minneapolis, MN 55455, United States.

Department of Neurosurgery, University of Louisville, 200 Abraham Flexner Hwy, Louisville, KY 40202, United States.

出版信息

J Clin Neurosci. 2023 May;111:86-90. doi: 10.1016/j.jocn.2023.03.009. Epub 2023 Mar 27.

DOI:10.1016/j.jocn.2023.03.009
PMID:36989768
Abstract

BACKGROUND

Intraoperative magnetic resonance imaging (iMRI) use in transsphenoidal approach (TSA) for pituitary tumors (PTs) has been reported to improve the extent of resection (EOR). The aim of this study is to report the trends and the impact of iMRI on healthcare utilization in patients who underwent TSA for PTs.

MATERIALS AND METHODS

MarketScan database were queried using the ICD-9/10 and CPT-4, from 2004 to 2020. We included patients ≥ 18 years of age PTs with > 1 year follow-up. Outcomes were length of stay (LOS), discharge disposition, hospital/emergency room (ER) re-admissions, outpatient services, medication refills and corresponding payments.

RESULTS

A cohort of 10,192 patients were identified from the database, of these 141 patients (1.4%) had iMRI used during the procedure. Use of iMRI for PTs remained stable (2004-2007: 0.85%; 2008-2011: 1.6%; 2012-2015:1.4% and 2016-2019: 1.46%). No differences in LOS (median 3 days each), discharge to home (93% vs. 94%), complication rates (7% vs. 13%) and payments ($34604 vs. $33050) at index hospitalization were noted. Post-discharge payments were not significantly different without and with iMRI use at 6-months ($8315 vs. $ 7577, p = 0.7) and 1-year ($13,654 vs. $ 14,054, p = 0.70), following the index procedure.

CONCLUSION

iMRI use during TSA for PTs remained stable with no impact on LOS, complications, discharge disposition and index payments. Also, there was no difference in combined index payments at 6-months, and 1-year after the index procedure in patients with and without iMRI use for PTs.

摘要

背景

术中磁共振成像(iMRI)在经蝶窦入路(TSA)治疗垂体瘤(PTs)中的应用已被报道可提高肿瘤全切除率(EOR)。本研究旨在报告 iMRI 在接受 TSA 治疗 PTs 的患者中的使用趋势及其对医疗保健利用的影响。

材料和方法

使用 ICD-9/10 和 CPT-4 从 2004 年至 2020 年在 MarketScan 数据库中进行查询。我们纳入了随访时间大于 1 年的年龄大于 18 岁的 PTs 患者。结果包括住院时间(LOS)、出院去向、医院/急诊室(ER)再入院、门诊服务、药物续配和相应的支付。

结果

从数据库中确定了 10192 例患者的队列,其中 141 例(1.4%)在手术过程中使用了 iMRI。PTs 中 iMRI 的使用保持稳定(2004-2007 年:0.85%;2008-2011 年:1.6%;2012-2015 年:1.4%和 2016-2019 年:1.46%)。住院期间的 LOS(中位数各为 3 天)、出院回家(93%与 94%)、并发症发生率(7%与 13%)和支付(34604 美元与 33050 美元)没有差异。在索引手术后 6 个月(8315 美元与 7577 美元,p=0.7)和 1 年(13654 美元与 14054 美元,p=0.70),没有 iMRI 与有 iMRI 应用的患者的出院后支付没有显著差异。

结论

PTs 经 TSA 中 iMRI 的使用保持稳定,对 LOS、并发症、出院去向和指数支付没有影响。此外,在有 iMRI 与无 iMRI 应用的患者中,在索引手术后 6 个月和 1 年的综合指数支付也没有差异。

相似文献

1
Intraoperative MRI use in transsphenoidal surgery for pituitary tumors: Trends and healthcare utilization.经蝶窦垂体瘤切除术术中磁共振成像的应用:趋势和医疗保健利用。
J Clin Neurosci. 2023 May;111:86-90. doi: 10.1016/j.jocn.2023.03.009. Epub 2023 Mar 27.
2
Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database.术中磁共振成像在恶性脑肿瘤手术中的应用是否会增加医疗负担?对 MarketScan 数据库的匹配分析。
J Neurooncol. 2022 Nov;160(2):331-339. doi: 10.1007/s11060-022-04142-0. Epub 2022 Oct 26.
3
Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.经术中磁共振成像辅助的经蝶窦垂体手术 10 年经验。
Neurosurg Focus. 2020 Jun;48(6):E14. doi: 10.3171/2020.3.FOCUS2072.
4
Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.垂体手术与切除范围的容积评估:术中磁共振成像应用的范式转变
Neurosurg Focus. 2016 Mar;40(3):E17. doi: 10.3171/2015.12.FOCUS15564.
5
Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.术中磁共振成像辅助下显微镜和经鼻内镜经蝶窦微创手术切除侵袭性较小的垂体腺瘤后肿瘤残余的特征。
Neurosurg Rev. 2022 Apr;45(2):1701-1708. doi: 10.1007/s10143-021-01705-z. Epub 2021 Dec 2.
6
Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.术中高场强磁共振成像用于无功能垂体腺瘤经蝶窦再次手术
J Neurosurg. 2014 Nov;121(5):1166-75. doi: 10.3171/2014.6.JNS131994. Epub 2014 Aug 15.
7
Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas.经蝶窦切除术治疗侵袭性垂体大腺瘤的术中磁共振成像。
Neurosurg Rev. 2019 Sep;42(3):737-743. doi: 10.1007/s10143-019-01102-7. Epub 2019 Apr 4.
8
Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases.北极星N20超低场术中磁共振成像系统在垂体大腺瘤切除控制中的可行性:来自前40例病例的经验教训。
Neurosurgery. 2008 Aug;63(2):272-84; discussion 284-5. doi: 10.1227/01.NEU.0000312362.63693.78.
9
The Zurich Pituitary Score predicts utility of intraoperative high-field magnetic resonance imaging in transsphenoidal pituitary adenoma surgery.苏黎世垂体评分预测经蝶窦垂体腺瘤手术中术中高场磁共振成像的效用。
Acta Neurochir (Wien). 2019 Oct;161(10):2107-2115. doi: 10.1007/s00701-019-04018-9. Epub 2019 Aug 7.
10
10 Years' Experience of Using Low-Field Intraoperative MRI in Transsphenoidal Surgery for Pituitary Adenoma: Results of the Swiss Pituitary Registry (SwissPit).低场术中磁共振成像在垂体腺瘤经蝶窦手术中的十年应用经验:瑞士垂体登记处(SwissPit)的结果
World Neurosurg. 2020 Apr;136:e284-e293. doi: 10.1016/j.wneu.2019.12.146. Epub 2019 Dec 31.

引用本文的文献

1
Observations from the first 100 cases of intraoperative MRI - experiences, trends and short-term outcomes.100 例术中磁共振成像的观察结果——经验、趋势和短期结果。
BMC Surg. 2024 Sep 19;24(1):268. doi: 10.1186/s12893-024-02569-y.